News Release Detail

February 9, 2012

Testimony of Mylan CEO Heather Bresch Before the U.S. Congress in Support of a Generic Drug User Fee Program

Testimony of Mylan CEO Hetaher Bresch Before the U.S. Congress in Support of a Generic Drug User Fee Program